JD Lee, EV Nunes, P Novo, K Bachrach, GL Bailey… - The Lancet, 2018 - thelancet.com
Background Extended-release naltrexone (XR-NTX), an opioid antagonist, and sublingual
buprenorphine-naloxone (BUP-NX), a partial opioid agonist, are pharmacologically and …